PT2931255T - Composições de gel - Google Patents

Composições de gel

Info

Publication number
PT2931255T
PT2931255T PT138154471T PT13815447T PT2931255T PT 2931255 T PT2931255 T PT 2931255T PT 138154471 T PT138154471 T PT 138154471T PT 13815447 T PT13815447 T PT 13815447T PT 2931255 T PT2931255 T PT 2931255T
Authority
PT
Portugal
Prior art keywords
gel compositions
gel
compositions
Prior art date
Application number
PT138154471T
Other languages
English (en)
Inventor
González Ojer Carlos
Maria Da Costa Martins Raquel
M Suñé Negre Josep
Miñarro Carmona Montserrat
Ramon Ticó Grau Josep
García Montoya Encarna
Pérez Lozano Pilar
Roig Carreras Manel
Sánchez Porqueres Natalia
Original Assignee
Laboratorios Ojer Pharma S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Ojer Pharma S L filed Critical Laboratorios Ojer Pharma S L
Publication of PT2931255T publication Critical patent/PT2931255T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015Drug-containing film-forming compositions, e.g. spray-on

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT138154471T 2012-12-17 2013-12-16 Composições de gel PT2931255T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12197473.7A EP2742932A1 (en) 2012-12-17 2012-12-17 Gel compositions

Publications (1)

Publication Number Publication Date
PT2931255T true PT2931255T (pt) 2017-01-04

Family

ID=47520732

Family Applications (1)

Application Number Title Priority Date Filing Date
PT138154471T PT2931255T (pt) 2012-12-17 2013-12-16 Composições de gel

Country Status (17)

Country Link
US (1) US9486403B2 (pt)
EP (2) EP2742932A1 (pt)
JP (1) JP6382215B2 (pt)
KR (1) KR102207658B1 (pt)
CN (1) CN104918605B (pt)
AU (1) AU2013363788B2 (pt)
BR (1) BR112015014180A8 (pt)
CA (1) CA2893656C (pt)
ES (1) ES2608794T3 (pt)
HK (1) HK1215197A1 (pt)
MX (1) MX349868B (pt)
NZ (1) NZ709219A (pt)
PL (1) PL2931255T3 (pt)
PT (1) PT2931255T (pt)
RU (1) RU2677892C2 (pt)
WO (1) WO2014095705A1 (pt)
ZA (1) ZA201504144B (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3838243A1 (de) * 2019-12-20 2021-06-23 Paul Hartmann AG Inkontinenzartikel mit ph-regulationsmittel
CN112023452B (zh) * 2020-08-19 2022-02-11 肇庆领誉环保实业有限公司 一种生活污水处理用消泡剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07223938A (ja) * 1994-02-09 1995-08-22 Saitama Daiichi Seiyaku Kk 貼付剤基剤
FR2776191B1 (fr) * 1998-03-23 2002-05-31 Theramex Composition hormonale topique a effet systemique
ITMI20022271A1 (it) * 2002-10-25 2004-04-26 Farmaka Srl Composizioni farmaceutiche bioadesive a base di anitiinfiammatori non steroidei.
WO2005074883A1 (en) * 2004-01-29 2005-08-18 Sinclair Pharmaceuticals Limited Aqueous compositions containing mixtures of synthetic polymers and biopolymers, useful in the treatment of skin and mucosal tissues dryness, and suitable as vehicles of active ingredients
US20100234336A1 (en) * 2005-11-14 2010-09-16 Erning Xia Ophthalmic Compositions
BRPI0717769A2 (pt) * 2006-10-17 2013-11-05 Nuvo Res Formulação de gel, método para o tratamento da osteoartrite em um indivíduo sofrendo de dor articular, e, uso de diclofenac de sódio
CN102038672B (zh) * 2009-10-10 2014-04-16 广东东阳光药业有限公司 一种用于治疗痤疮的药物组合物
EP2444067A1 (en) 2010-10-20 2012-04-25 Laboratorios Ojer Pharma S.L. Anhydrous gel comprising mupirocin
RU2567791C2 (ru) * 2010-12-22 2015-11-10 Колгейт-Палмолив Компани Композиции для ухода за полостью рта
JP5572110B2 (ja) * 2011-02-08 2014-08-13 アクセス ファーマシューティカルズ, インコーポレイテッド 粘膜の疾患および障害の予防および処置のための液体製剤

Also Published As

Publication number Publication date
KR20150095898A (ko) 2015-08-21
MX349868B (es) 2017-08-17
BR112015014180A2 (pt) 2017-07-11
RU2015129081A (ru) 2017-01-25
AU2013363788A1 (en) 2015-07-09
RU2677892C2 (ru) 2019-01-22
JP6382215B2 (ja) 2018-08-29
EP2931255B1 (en) 2016-10-19
CN104918605A (zh) 2015-09-16
CA2893656C (en) 2020-11-03
JP2016502993A (ja) 2016-02-01
BR112015014180A8 (pt) 2019-10-22
EP2742932A1 (en) 2014-06-18
ZA201504144B (en) 2017-03-29
US9486403B2 (en) 2016-11-08
KR102207658B1 (ko) 2021-01-26
EP2931255A1 (en) 2015-10-21
MX2015007347A (es) 2015-09-10
US20150343066A1 (en) 2015-12-03
AU2013363788B2 (en) 2016-06-23
WO2014095705A1 (en) 2014-06-26
ES2608794T3 (es) 2017-04-17
HK1215197A1 (zh) 2016-08-19
CA2893656A1 (en) 2014-06-26
CN104918605B (zh) 2017-09-15
PL2931255T3 (pl) 2017-06-30
NZ709219A (en) 2019-06-28

Similar Documents

Publication Publication Date Title
HK1215165A1 (zh) 組合物
HK1210019A1 (en) Chitosan-derived compositions
HK1208354A1 (en) Compositions
ZA201503157B (en) Compositions
GB201210800D0 (en) Compositions
GB201209244D0 (en) Compositions
GB201201287D0 (en) Compositions
IL229696A0 (en) Gel preparations
GB201222406D0 (en) Gel compositions
HK1215197A1 (zh) 凝膠組合物
ZA201503062B (en) Compositions
GB201222405D0 (en) Gel compositions
GB201220068D0 (en) Compositions
ZA201502542B (en) Compositions
GB201222403D0 (en) Gel compositions
EP2825154A4 (en) LONG ACTIVE COMPOSITIONS
GB201219973D0 (en) Compositions
GB201219962D0 (en) Compositions
GB201219980D0 (en) Compositions
GB201222407D0 (en) Gel compositions
TWI561248B (en) Peracid-generating compositions
EP2926813A4 (en) METFORMIN-Orlistat COMPOSITIONS
GB201223148D0 (en) Compositions
GB201222702D0 (en) Compositions
GB201218959D0 (en) Compositions